Results 51 to 60 of about 23,072 (216)

Assessment of Thyroid Uptake Ratio Values in a Normal Population. Establishment of Normal Reference Values for 99mTc‐Pertechnetate Thyroid Uptake in an Australian Population

open access: yesJournal of Medical Radiation Sciences, EarlyView.
An Australian first, this study examined normal reference ranges for 99mTc‐pertechnetate thyroid uptake. Through a retrospective and prospective analysis, this study found a new reference range of 0.4%–2.4%. The findings suggest that locally derived reference values may differ from historical data and highlight the importance of region‐specific ...
Bethany Wornes   +2 more
wiley   +1 more source

- Subclinical Hypothyroidism

open access: yesThe Professional Medical Journal, 2012
Chronic kidney disease (CKD) is characterized by progressive destruction of renal mass with irreversible sclerosis andloss of nephrons.Various metabolic, hematological and endocrine abnormalities are known to occur in CKD. Subclinical hypothyroidismis an important endocrine abnormality associated with a greater cardiovascular risk, atherosclerosis and ...
MOHAMMAD ASIF   +2 more
  +5 more sources

Evaluation of Serum Prolactin Level in Patients of Subclinical and Overt Hypothyroidism [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2015
Background: Prolactin secretion is controlled by prolactin inhibitor factor that is secreted from hypothalamus; factors like vasoactive inhibitory peptide (VIP) and thyroid releasing hormone (TRH) lead to increase in prolactin secretion ...
Parul Goel   +4 more
doaj   +1 more source

Monitoring thyroid function status in elderly patients on amiodarone [PDF]

open access: yes, 2006
Objectives: To evaluate whether elderly patients on amiodarone were having their thyroid function status monitored as recommended in the literature and to identify the frequency and type of thyroid function test abnormalities noted.
Fiorini, Anthony
core  

Subclinical hypothyroidism and cardiovascular risk: how to end the controversy

open access: yes, 2013
The indications for screening and TSH threshold levels for treatment of subclinical hypothyroidism have remained a clinical controversy for over 20 years.
Rodondi, Nicolas, Bauer, Douglas C
core   +1 more source

Fetal Heart Rate at 12 Weeks' Gestation and the Risk of Preterm Birth

open access: yesJournal of Ultrasound in Medicine, EarlyView.
Objectives To prospectively validate the association between fetal heart rate (FHR) at the 12‐week scan and the risk of preterm birth (PTB), including spontaneous preterm birth (sPTB). Methods This prospective cohort study included 1276 singleton pregnancies undergoing routine first‐trimester screening at 11–13 + 6 weeks' gestation and followed until ...
José Morales‐Roselló   +3 more
wiley   +1 more source

To Treat or Not to Treat Subclinical Hypothyroidism, What Is the Evidence?

open access: yesMedicina, 2020
Objective: levothyroxine prescriptions have increased remarkably during the last decade, and it is most likely to be prescribed in subclinical hypothyroidism. The aim of this review was to present data on when levothyroxine treatment should be initiated,
Jan Calissendorff, Henrik Falhammar
doaj   +1 more source

Outcomes in the Management of Pediatric Retrograde Cricopharyngeal Dysfunction

open access: yesThe Laryngoscope, EarlyView.
ABSTRACT Objective To review the presentation and treatment outcomes of pediatric patients with retrograde cricopharyngeal dysfunction (RCPD). Methods A retrospective chart review was performed on pediatric patients diagnosed with retrograde cricopharyngeal dysfunction (RCPD) and treated with cricopharyngeal botulinum toxin injection (CPBTI).
Aidan P. Wright   +3 more
wiley   +1 more source

Subclinical hypothyroidism in older individuals

open access: yes, 2022
Subclinical hypothyroidism, which is defined as a thyroid-stimulating hormone concentration higher than the reference range (generally 4·5 mIU/L or higher) with normal free thyroxine concentrations, is frequently found in older individuals. International
Biondi ,B   +3 more
core   +1 more source

Ashwagandha: Is It Safe? Part 2: A Preclinical Evidence Review

open access: yesPhytotherapy Research, EarlyView.
ABSTRACT The preclinical evidence for the safety of ashwagandha (Withania somnifera (L.) Dunal, AS) is reviewed, and its preparations (extracts) and constituents, from the general toxicity in animal models to in vitro and cell culture studies, which may elucidate mechanisms of action and explain clinical case reports.
Elizabeth M. Williamson, Thomas Brendler
wiley   +1 more source

Home - About - Disclaimer - Privacy